Zusammenfassung
Der Geburtshilfe steht durch die molekulare Medizin eine enorme Entwicklung bevor. In der pränatalen Diagnostik und der Grundlagenforschung zur Frühgeburtlichkeit sowie Präeklampsie haben sich bereits bedeutende Neuerungen in Diagnostik und bei den Therapieansätzen ergeben. Neue Richtungen in der Medizin müssen aber Grenzen erkennen, die wissenschaftlich, ärztlich und gesellschaftlich zu definieren sein werden.
Abstract
Molecular medicine has made substantial contributions to the development of obstetrics over the past 30 years. A number of new diagnostic possibilities and therapeutic approches are being introduced in the fields of prenatal diagnosis and early research in preterm labor and preeclampsia. Looking ahead, molecular medicine in obstetrics requires public, scientific, and medical debate leading to clinical guidance.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Aidoo M, McElroy PD, Kolcyak MS, Terlouw DJ (2001) Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol 21: 2002–2011
Beckmann MW (2002) Molekulare Frauenheilkunde. Gynäkologe 35: 872
Carr-Hill RA, Hall MH (1985) The repetition of spontaneous preterm labour. Br J Obstet Gynaecol 92: 921–928
Cincotta RB, Brennecke SP (1998) Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynecol Obstet 60: 23
Crider KS, Whitehead N, Buus RM (2005) Genetic variation associated with preterm birth: A HuGE review. Genet Med 7: 593
Esplin M, Fausett M, Frase A et al. (2001) Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344: 867
Hoffmann HJ, Bakketeig LS (1984) Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol 27: 539–552
Johnstone F, Inglis L (1974) Familial trends in low birth weight. BMJ 3: 659–661
Lachmaijer AMA, Arngrimsson R, Bastiaans EJ et al. (2001) A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet 9: 758
Lachmaijer AMA, Dekker GA, Pals G et al. (2002) Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 105: 94
Lamont RF (2003) Recent evidence associated with the condition of preterm prelabour rupture of the membranes. Curr Opin Obstet Gynecol 15: 91
Lie RT, Rasmussen S, Brunborg H et al. (1998) Fetal and maternal contributions to risk of pre-eclampsia: population based study 316: 1343
Moses EK, Johnson MP, Tommerdal L, Forsmo S et al. (2008) Genetic association of preeclampsia to the inflammatory response gene SEPS1. Amer J Obstet Gynecol 198: 336
Romero R, Avila C, Brekus CA, Marotti R (1991) The role of systemic and intrauterine infection in preterm parturition. Ann NY Acad Sci 622: 355–375
Schümer D (2000) Die lukrativen Gene der Wikinger. Island wird zum Labor der Biotechnologie. Frankfurter Allgemeine Zeitung vom 16.09.2000
Unschuld PU (2008) Wunschmedizin. 37. Jahrestagung der Deutschen Gesellschaft für Psychosomatische Frauenheilkunde und Geburtshilfe. Berlin
Xu H, Gonzalez JM, Ofori E, Elovitz MA (2008) Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth? Amer J Obstet Gynecol 198: 314
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dudenhausen, J. Molekulare Medizin in der Geburtshilfe. Gynäkologe 41, 667–671 (2008). https://doi.org/10.1007/s00129-008-2188-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-008-2188-7